Charak Samhita

Talk:Jeeraka: Difference between revisions

← Older edit
VisualWikitext
Dridhabala (talk | contribs)
239 edits
No edit summary
Dridhabala (talk | contribs)
239 edits
No edit summary
 
Line 214: Line 214:


== Phytochemical Composition ==
== Phytochemical Composition ==
The therapeutic efficacy of ''Cuminum cyminum'' is attributed to its rich volatile oil and bioactive secondary metabolite profile, which includes:
The seeds of ''Cuminum cyminum'' are a rich source of essential oil, and its chemistry has been extensively studied.<ref name="ref3">Johri RK. Cuminum cyminum and Carum carvi: An update. ''Pharmacogn Rev''. 2011;5(9):63-72. doi:10.4103/0973-7847.79101</ref> The main groups of constituents are:
* '''Volatile Oils:''' Cuminaldehyde, γ-terpinene, p-cymene, and β-pinene.
* '''Volatile oil:''' Cuminaldehyde (the principal aldehyde), γ-terpinene, p-cymene and β-pinene.
* '''Flavonoids & Polyphenols:''' Apigenin, luteolin, and various glycosides.
* '''Flavonoids and other polyphenols:''' Contribute to the antioxidant profile of the seed.
* '''Other Constituents:''' Fixed oils, proteins, and essential minerals.
* '''Other constituents:''' Fixed oil, proteins and minerals.


== Pharmacological Activities & Therapeutic Efficacy ==
== Pharmacological Activities & Therapeutic Efficacy ==
=== Gastrointestinal and Carminative Effects ===
Jeeraka is traditionally and scientifically validated for its powerful carminative and digestive properties.
* '''Mechanism:''' It stimulates the secretion of pancreatic enzymes and bile acids, enhancing nutrient absorption and relieving abdominal distension.
* '''Scientific Evidence:''' Experimental studies demonstrate that cumin extracts significantly reduce gastric acidity and protect against mucosal damage<ref name="ref3">Johri, R. K. (2011). Cuminum cyminum and sa-jeera: a review of their antidiabetic, antioxidant and gastroprotective effects. *Pharmacognosy Reviews*, 5(9), 63–72.</ref>


=== Antidiabetic and Hypolipidemic Properties ===
=== Gastroprotective and Antioxidant Effects ===
Modern pharmacological studies show that cumin helps manage blood glucose and lipid profiles.
Jeeraka is traditionally used as a digestive (dipana-pachana) drug. In experimental work, the methanol extract of cumin seeds (400 mg/kg) reduced the fasting-induced gastric ulcer score in streptozotocin-diabetic rats, restored gastric mucus glycoprotein content, raised mucosal glutathione and catalase, and lowered gastric TNF-α and lipid peroxidation. The same extract scavenged DPPH and superoxide radicals in vitro (IC<sub>50</sub> about 300 and 1131 µg/ml respectively).<ref name="ref4">Vador N, Jagtap AG, Damle A. Vulnerability of gastric mucosa in diabetic rats, its pathogenesis and amelioration by ''Cuminum cyminum''. ''Indian J Pharm Sci''. 2012;74(5):387-396. doi:10.4103/0250-474X.108413</ref>
* '''Mechanism:''' Its active constituents improve insulin sensitivity and exhibit antioxidant activity that protects pancreatic beta cells.
* '''Scientific Evidence:''' Research indicates that oral administration of cumin seed powder lowers fasting blood glucose and serum cholesterol levels in diabetic models<ref name="ref4">Jagtap, A. G., & Patil, P. B. (2010). Antihyperglycemic and antioxidant activity of Cuminum cyminum in streptozotocin-induced diabetic rats. *Journal of Pharmacy and Pharmacology*, 62(7), 917–923.</ref>


=== Antimicrobial and Antioxidant Actions ===
=== Antidiabetic Activity ===
Cumin exhibits broad-spectrum activity against various bacterial and fungal strains.
Cuminaldehyde and cuminol, isolated from the petroleum ether fraction of cumin distillate, were identified as insulinotropic components. In streptozotocin-induced diabetic rats, the fraction lowered blood glucose without causing hypoglycaemia or β-cell exhaustion, and 45 days of administration improved the lipid profile.<ref name="ref5">Patil SB, Takalikar SS, Joglekar MM, Haldavnekar VS, Arvindekar AU. Insulinotropic and β-cell protective action of cuminaldehyde, cuminol and an inhibitor isolated from ''Cuminum cyminum'' in streptozotocin-induced diabetic rats. ''Br J Nutr''. 2013;110(8):1434-1443. doi:10.1017/S0007114513000627</ref>
* '''Mechanism:''' Essential oil components like cuminaldehyde disrupt microbial cell membranes, inhibiting pathogen growth.
 
* '''Scientific Evidence:''' In vitro evaluations confirm significant inhibitory zones against foodborne pathogens and multi-drug resistant strains<ref name="ref5">Beigi, M., & Tavakoli, H. (2018). Chemical composition and antimicrobial activity of Cuminum cyminum essential oil. *Journal of Essential Oil Bearing Plants*, 21(4), 1052–1060.</ref>
=== Hypolipidemic Activity ===
A hypolipidemic effect of ''Cuminum cyminum'' has been reported in alloxan-induced diabetic rats.<ref name="ref6">Dhandapani S, Subramanian VR, Rajagopal S, Namasivayam N. Hypolipidemic effect of ''Cuminum cyminum'' L. on alloxan-induced diabetic rats. ''Pharmacol Res''. 2002;46:251-255. doi:10.1016/S1043-6618(02)00131-7</ref>
 
=== Antimicrobial Activity ===
The essential oil of cumin (main components: cuminaldehyde 27.10%, β-pinene 25.04% and γ-terpinene 15.68%) showed antibacterial activity against all the tested major food-borne pathogenic bacteria, and cuminaldehyde was identified as a major bioactive component.<ref name="ref7">Wongkattiya N, et al. Antibacterial activity of cuminaldehyde on food-borne pathogens, the bioactive component of essential oil from ''Cuminum cyminum'' L. collected in Thailand. ''J Complement Integr Med''. 2019;16(4). doi:10.1515/jcim-2018-0195</ref>


== Safety, Toxicity, and Dosage ==
== Safety, Toxicity, and Dosage ==
* '''Acute Toxicity:''' Cumin is safe for culinary and therapeutic consumption with a high safety profile.
* '''Acute Toxicity:''' In rats, a single oral dose of 2000 mg/kg of the methanol extract caused no morbidity or mortality over 14 days of observation.<ref name="ref4"/>
* '''Precautions:''' Use with caution in high Pitta conditions or excessive bleeding disorders due to its hot (ushna) potency.
* '''Precautions:''' Use with caution in high Pitta conditions or excessive bleeding disorders due to its hot (ushna) potency (traditional precaution).
* '''Standard Therapeutic Dosage:'''  
* '''Standard Therapeutic Dosage:'''  
** ''Seed Powder (Churna):'' 1–3 g daily with warm water or honey<ref name="ref1"/>.
** ''Seed Powder (Churna):'' 1–3 g daily with warm water or honey<ref name="ref1"/>.
Line 245: Line 243:
|+ Therapeutic Applications of ''Cuminum cyminum''
|+ Therapeutic Applications of ''Cuminum cyminum''
! Indication
! Indication
! Active Biomolecules
! Active Constituent / Preparation
! Primary Pharmacological Action
! Reported Action
|-
|-
| '''Indigestion / Agnimandya'''
| '''Indigestion / Agnimandya'''
| Cuminaldehyde, Terpenes
| Seed powder (traditional); methanol extract (experimental)
| Digestive stimulant, Carminative
| Digestive (dipana-pachana); gastroprotective and antioxidant in rats
|-
|-
| '''Diarrhoea / Atisara'''
| '''Hyperglycemia'''
| Tannins, Volatile oils
| Cuminaldehyde, cuminol
| Astringent, Antimicrobial
| Insulinotropic, β-cell protective
|-
|-
| '''Hyperglycemia'''
| '''Dyslipidemia'''
| Polyphenols, Flavonoids
| Cumin seed (diabetic rat model)
| Insulin sensitization, Antioxidant
| Hypolipidemic
|-
| '''Bacterial infection (food-borne pathogens)'''
| Essential oil, cuminaldehyde
| Antibacterial
|}
|}


Line 265: Line 267:
<ref name="ref1">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 1 :34</ref>
<ref name="ref1">Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 1 :34</ref>
<ref name="ref2">Pro. Krushnachandra Chunekar, Bhavaprakash Nighantu, Reprint Edition 2020, Chaukhambha Bharati Academy, Haritakyadi varga, verse no.-81,82</ref>
<ref name="ref2">Pro. Krushnachandra Chunekar, Bhavaprakash Nighantu, Reprint Edition 2020, Chaukhambha Bharati Academy, Haritakyadi varga, verse no.-81,82</ref>
<ref name="ref3">Johri, R. K. (2011). Cuminum cyminum and sa-jeera: a review of their antidiabetic, antioxidant and gastroprotective effects. *Pharmacognosy Reviews*, 5(9), 63–72.</ref>
<ref name="ref3">Johri RK. Cuminum cyminum and Carum carvi: An update. ''Pharmacogn Rev''. 2011;5(9):63-72. doi:10.4103/0973-7847.79101</ref>
<ref name="ref4">Jagtap, A. G., & Patil, P. B. (2010). Antihyperglycemic and antioxidant activity of Cuminum cyminum in streptozotocin-induced diabetic rats. *Journal of Pharmacy and Pharmacology*, 62(7), 917–923.</ref>
<ref name="ref4">Vador N, Jagtap AG, Damle A. Vulnerability of gastric mucosa in diabetic rats, its pathogenesis and amelioration by ''Cuminum cyminum''. ''Indian J Pharm Sci''. 2012;74(5):387-396. doi:10.4103/0250-474X.108413</ref>
<ref name="ref5">Beigi, M., & Tavakoli, H. (2018). Chemical composition and antimicrobial activity of Cuminum cyminum essential oil. *Journal of Essential Oil Bearing Plants*, 21(4), 1052–1060.</ref>
<ref name="ref5">Patil SB, Takalikar SS, Joglekar MM, Haldavnekar VS, Arvindekar AU. Insulinotropic and β-cell protective action of cuminaldehyde, cuminol and an inhibitor isolated from ''Cuminum cyminum'' in streptozotocin-induced diabetic rats. ''Br J Nutr''. 2013;110(8):1434-1443. doi:10.1017/S0007114513000627</ref>
<ref name="ref6">Dhandapani S, Subramanian VR, Rajagopal S, Namasivayam N. Hypolipidemic effect of ''Cuminum cyminum'' L. on alloxan-induced diabetic rats. ''Pharmacol Res''. 2002;46:251-255. doi:10.1016/S1043-6618(02)00131-7</ref>
<ref name="ref7">Wongkattiya N, et al. Antibacterial activity of cuminaldehyde on food-borne pathogens, the bioactive component of essential oil from ''Cuminum cyminum'' L. collected in Thailand. ''J Complement Integr Med''. 2019;16(4). doi:10.1515/jcim-2018-0195</ref>
}}
}}


[[Index.php?title=Category:Database of herbs and minerals| Herbs]]
[[Index.php?title=Category:Database of herbs and minerals| Herbs]]
Retrieved from "https://www.charakasamhitauptodate.com/index.php?title=Talk:Jeeraka"
Return to "Jeeraka" page.